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Abstract: Management of drug therapy in nursing home patients is challenging due to complex 
health problems, use of multiple medications, and age-related changes in pharmacokinetics and 
pharmacodynamics. The objective of this study was, first, to examine the effect of systematic 
medication reviews conducted by multidisciplinary nursing home teams on prescribing quality 
and, second, to evaluate if drug therapy changes were maintained over time. Patients in a large 
nursing home in Oslo, Norway, were prospectively followed during a 1.5-year period. Systematic 
comprehensive medication reviews were carried out and the identified drug-related problems 
(DRPs) were discussed at multidisciplinary team meetings. After 3 months, the patients’ drug 
regimens were reviewed again to evaluate if drug therapy changes were maintained. Altogether, 
93 patients were included (89% women, mean age 87 years). In total, 234 DRPs were identified 
in 82 patients, and 151 drug therapy changes were performed in 73 patients. The most common 
DRPs were ‘drug treatment without a clear indication’ (37% of all DRPs) and ‘treatment with 
an inappropriate drug’ (20%). After 3 months, 85 patients (91%) were available for follow-up. 
In these patients, 133 (88%) of the drug therapy changes were maintained, and the mean number 
of DRPs had decreased from 2.6 to 1.0 per patient (P , 0.01). We were able to demonstrate 
that medication reviews conducted by multidisciplinary teams were effective to improve 
the quality of drug treatment in nursing home patients by significantly reducing both number 
of drugs and number of DRPs. The large majority of drug therapy changes were maintained 
after 3 months.
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Introduction
Nursing homes represent the largest institutional level in Norway, with about 
40,000 beds, comprising about 14% of Norwegian citizens aged 80 years and over.1 
Nursing home patients commonly suffer from complex health problems leading to 
polypharmacy. The complexity of drug therapy for these patients and age-related 
changes in pharmacokinetics and pharmacodynamics increase the risk of drug-related 
problems (DRPs) and make appropriate drug prescribing challenging. Norwegian 
nursing homes have registered nurses who administer drugs to patients. Although 
qualified nursing staff is available at all hours, medical care in nursing homes is most 
commonly provided by part-time engaged general practitioners. Research suggests a 
need for improved medication management in nursing homes.2,3 Inappropriate pre-
scribing is associated with increased morbidity, hospitalization, and mortality4,5 and 
has important economical implications.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
10
Davidsson et al
In the United States and Australia, quality of care for the 
elderly has been studied extensively, and managed care 
programs involving clinical pharmacists have been imple-
mented in primary care. In Europe, such programs are scarce, 
except for the United Kingdom. Medication reviews in   nursing 
homes by pharmacists are promising but not conclusive, and 
only few studies have had a multidisciplinary approach.6–10 
Multidisciplinary team interventions including clinical phar-
macists are effective to resolve DRPs in hospital settings,11 
and a similar approach is expected to improve the quality of 
drug therapy in nursing homes.
The objective of this study was to examine the effect of 
systematic medication reviews conducted by multidisci-
plinary nursing home teams on prescribing quality and to 
evaluate if drug therapy changes were maintained over time.
Methods
study population
A clinical pharmacist (author MD) prospectively recruited 
patients from one nursing home in Oslo, Norway, during a 
1.5-year period from 2005 to 2007. In total, the nursing home 
comprised 127 beds on five different wards. Patients were 
enrolled ward by ward, but due to shortage of nursing staff, 
we were unable to include 34 patients from one of the wards.
Based on drug charts and medical records, the clinical 
pharmacist retrieved the following information for each 
patient: age, gender, all regular medications (brand name, 
formulation, strength, and dose), active medical conditions, 
and relevant laboratory tests (eg, glomerular filtration rate). 
The drugs were classified according to the Anatomical 
Therapeutic Chemical (ATC) classification system.12
The study was reported to the Regional Committee for 
Medical and Health Research Ethics, who presented no 
objection regarding the study design but concluded that 
committee clearance was not required. They regarded the 
project as quality improvement of medical care, implying 
that it was not necessary to obtain informed consent from 
the study participants. However, an information letter was 
sent to all patients and to patients’ next of kin if the patients 
were diagnosed with dementia.
DrPs
The clinical pharmacist reviewed patients’ drug list to   identify 
DRPs, taking into account individual clinical characteristics. 
Norwegian drug therapy guidelines and a drug–drug interac-
tion database were used as tools.13,14 A DRP was defined 
according to the Pharmaceutical Care Network Europe: 
‘an event or circumstance involving drug therapy that   actually 
or potentially interferes with desired health outcomes’.15 
The identified DRPs were classified according to a slightly 
modified Norwegian classification system.16 Nine DRP cat-
egories were applied: 1) treatment without clear indication, 
2) inappropriate drug, 3) need for additional drug, 4) too high 
dose, 5) too low dose, 6) suboptimal dosing time or formu-
lation, 7) adverse drug reactions (only those that are unavoid-
able and show symptoms are included), 8) lack of monitoring, 
and 9) drug–drug interaction. These DRPs are all potential 
causes of unfavorable clinical outcomes. Although classified 
as DRPs in many studies, in this study, preventable adverse 
events (ADEs) or therapeutic failure were regarded to be 
symptoms of the underlying causes; therefore, ADE is not 
included as a separate category in the DRP registration.
The identified DRPs were discussed with the physician 
and nurses in charge at regular multidisciplinary case con-
ferences, and drug therapy changes were suggested. The 
nursing home physician held the final decision whether drug 
therapy changes should be performed or not. After 3 months, 
the patients’ drug charts were reviewed again by the clini-
cal pharmacist to evaluate if drug therapy changes were 
  maintained. The change in number of DRPs was used as a 
measure of improvement in prescribing quality.
statistical analyses
Changes in numbers of drugs used and numbers of DRPs 
before and 3 months after the multidisciplinary case 
  conferences were analyzed by Wilcoxon signed rank test. 
P values ,0.05 were regarded as statistically significant. 
SPSS software (version 15.0 for Windows; SPSS Inc., 
  Chicago, IL) was used for the analyses.
Results
Altogether, 93 nursing home patients were included. Women 
comprised 89% of the population and mean age was 87 years 
(SD, 8.3; range, 52–102). The patients used an average of 
7.5 regular drugs. The most commonly used drugs were 
analgesics (ATC groups N02 and M01), which were used by 
70% of the patients, laxatives (ATC group A06A) (67%), 
antidepressants (ATC group N06A) (46%), loop diuretics 
(ATC group C03C) (42%), and antithrombotic drugs (ATC 
group B01) (46%).
The pharmacist identified 234 DRPs in 82 (88%) of the 
patients. The number of DRPs per patient ranged from 0 to 
7 (average, 2.5 DRPs/patient). After discussion with the 
multidisciplinary teams, 151 drug therapy changes were 
performed in 73 patients. Table 1 shows that the most com-
monly acknowledged DRPs were ‘drug treatment without a Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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clear indication’, ‘inappropriate drug choice’, and ‘drug–drug 
interaction’.
Eighty-five (91%) patients were eligible for follow-up 
after 3 months. Seven patients had died and one was hospital-
ized, and, therefore, nine drug therapy changes performed 
in these patients were not available for follow-up. Altogether, 
133 (88%) of the changes performed after multidisciplinary 
case conferences were maintained after 3 months.
Of the 234 DRPs discussed, 151 (65%) were acted upon. 
For the remaining DRPs, changes were not performed 
(Table 1). ‘Suboptimal dosing time or formulation’, ‘too high 
dose’, and ‘need for additional drug’ were the DRPs that 
most frequently led to drug therapy changes (Table 2). On 
the other hand, ‘drug–drug interaction’ was least likely to 
bring about changes. Drug discontinuation (44% of all drug 
therapy changes) and dose adjustment (32%) were the most 
common changes.
Three months after intervention, the average number of 
drugs used per patient had decreased from 7.4 (SD = 3.3) to 
6.8 (SD = 3.5), P , 0.01, while the number of DRPs per 
patient had decreased from 2.52 (SD = 1.7) to 1.05 (SD = 1.4), 
P , 0.01.
Table 1 number (and %) of DrPs discussed in the multidisciplinary team, changes made, changes maintained after 3 months, and drugs 
most frequently associated with DrPs in 93 nursing home patients
Type of DRP  
discussed
N (%) Management outcome Drugs most frequently 
involved (number of times 
with DRPs)
Changes not 
made, N (%)
Changes  
made, N (%)
Changes maintained  
after 3 months (% of the   
changes made), N (%)
Treatment without  
clear indication
87 (37) 34 (39) 53 (61) 43 (81) Acetylsalicylic acid (7), 
citalopram (7), furosemide (8), 
haloperidol (4)
inappropriate  
drug choice
46 (20) 22 (48) 24 (52) 20 (83) Hydroxyzine (7), zopiclone (3), 
senna glycosides (3), 
alimemazine (3)
Drug–drug interaction 26 (11) 16 (62) 10 (38) 8 (80) Paracetamol/codeine 
combination (9), metoprolol (5), 
oxazepam (6), escitalopram (4)
Too high dose 24 (10) 4 (17) 20 (83) 20 (100) Furosemide (4), memantine (2), 
sodium picosulfate (2)
Too low dose 22 (9) 6 (27) 16 (73) 15 (94) Paracetamol (6), calcium/ 
vitamin D combination (2)
Lack of monitoring 18 (8) 0 18 (100) – Levothyroxine sodium (4),  
enalapril (4)
suboptimal dosing  
time or formulation
6 (3) 0 6 (100) 5 (83) –
need for additional drug 5 (2) 1 (20) 4 (80) 4 (100) –
Adverse drug reactions 0 0 – – –
Total 234 (100) 83 (35) 151 (65) 133 (88) –
Table 2 Type of changes made according to DrP category
Type of change DRP category
No clear 
indication 
for drug use
Inappropriate  
drug choice
Drug–drug 
interaction
Too 
high 
dose
Too 
low 
dose
Lack of 
monitoring
Suboptimal 
dosing time or 
formulation
Need for 
additional 
drug
Total
Drug  
discontinuation
40 15 1 1 – – 1 – 58
Dose adjustment 2 2 4 18 15 – 1 – 42
Monitoring – – 3 1 – 18 – – 22
Drug switch/change  
of administration
1 3 – – – – 3 1 8
Addition of a new drug – – – – – – – 3 3
Total 43 20 8 20 15 18 5 4 133
Notes: Data collected 3 months after intervention.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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Discussion
In the present study, DRPs were identified in nearly 90% of 
the patients. Following multidisciplinary case conferences, 
the average numbers of DRPs were significantly reduced by 
60% from 2.6 to 1.3. Moreover, almost 90% of the changes 
were maintained after 3 months. These results indicate that 
medication reviews conducted by multidisciplinary teams 
are effective to improve the quality of drug treatment in 
nursing home patients.
To our knowledge, only a few studies using a comparable 
multidisciplinary model in nursing homes have previously 
been conducted (ie, two Dutch studies,17,18 one Swedish 
study,19 one Australian study,8 and two Norwegian studies).9,10 
All these studies have shown a positive effect of this model 
on drug prescribing quality. Two studies used the Medication 
Appropriateness Index (MAI) to measure quality.8,18 Stuijt 
et al demonstrated an improvement in mean summed MAI 
from 23.7 before intervention to 16.0 after the intervention 
period (P = 0.013), while Crotty et al showed a change in the 
MAI with 4.1 in the intervention group compared to 0.4 in 
the control group (P , 0.001). In one of the other studies, 
a reduction of 1.7 problems per patient was shown,17 which 
is comparable to our study. In line with our findings, this 
latter study also demonstrated a reduction in the overall drug 
use.17 Reduced drug use is probably an indicator of medication 
quality in this aging population, and it also implies substan-
tially reduced costs for the nursing homes over time.
In our study, systematic medication reviews by a clinical 
pharmacist followed by face-to-face multidisciplinary case 
conferences were used to identify and resolve DRPs in a 
nursing home. Verrue et al performed a systematic review 
on pharmacists’ interventions for the optimization of drug 
use and found mixed evidence for the effectiveness in the 
nursing home setting.20 One reason could be that in most 
studies, the pharmacist interventions have been in written 
form, that is, do not imply a direct communication with 
prescribers.7,21–23 In the United States, legislation demands 
monthly medication reviews (written comments) in nursing 
homes,24,25 and although clinical pharmacy services in the 
United States  nursing homes have proven to reduce mor-
bidity and mortality, DRPs are often reported in nursing 
homes.26 This is the reason why a new model implementing 
direct communication between professions has been sug-
gested in the United States: the Fleetwood model of phar-
maceutical care.25 Our findings support that direct 
communication between pharmacists and physicians is 
useful to obtain attention for DRPs and also accept for drug 
therapy changes in nursing homes.
Our study revealed DRPs in a large majority of nursing 
home patients (88%), which is in accordance with previous 
studies.2,5 Moreover, in line with previous studies, we found 
‘lack of indication’ to be the most common DRP.17–19 The 
high prevalence of this type of problem could be due to 
administrative system errors, for example lack of transmis-
sion of information when a patient moves into the nursing 
home, incomplete medical records, or suboptimal systems 
for monitoring of drug therapy.
Two-thirds of the performed medication changes com-
prised drug discontinuation or dose adjustment. These are 
changes that also have the potential to provide negative clini-
cal outcomes for the patients. However, the fact that almost 
90% of the changes were maintained after 3 months suggests 
the opposite. Three months is probably sufficient time to 
discover adverse effects of the changes such as the medical 
condition worsens after discontinuation of a drug. Thus, it 
could be interpreted that the interventions actually improved 
the quality of drug prescribing in the nursing home. Some 
of the identified DRPs discussed by the multidisciplinary 
team were decided not to act upon, and drug interactions 
were the type of DRP that were least intervened on. One of 
the reasons may be difficulty in communicating the potential 
outcome of the DRP to the physician or difficulty in finding 
more appropriate drug substitutes.
The strength of our study is the prospective approach 
and that the multidisciplinary case conferences were 
included in the regular clinical setting. Furthermore, the 
clinical pharmacist added to the team had vast experience 
in clinical work. The limitations are, of course, that the study 
was conducted in only one nursing home with one pharma-
cist. However, the present study provides evidence to pos-
tulate that joining intellectual forces in multidisciplinary 
teams can reduce both the number of drugs and the number 
of DRPs in nursing homes and, furthermore, that the vast 
majority of drug regimen changes maintains over time. 
Despite the limited sample size, the results indicate that 
medication reviews conducted by multidisciplinary teams 
are effective in improving quality of drug treatment in nurs-
ing home patients.
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